3Gastaldelli A, Kozakova M, Balkan B, et al. 36 fatty liver index is associated with increased insulin resistance and carotid intima media thickness(imt) in non- diabetic subjects: the risk study [J]. Hepatology, 2008, 48 (2) :16.
4Fujita N, Miyachi H, Tanaka H, et al. Iron overload is associated with hepatic oxidative damage to DNA in nonalcoholic steatohepatitis [J]. Cancer epidemiol Bio Prev, 2009,18(2):424-432.
5Bigorgne AE, Bouchet-Delbos L, Navean S, et al. Obesity-induced lymphocyte hyperresponsiveness to chemokines: a new mechanism of fatty liver inflammation in obese mice [J]. Gastroenterology, 2008, 134(5):1459-1469.
6Hui JM, Hodge A, Kench JG, et al. Beyond insulin resistance in NASH: TNF-α or adiponectin[ J] ? Hepatology, 2004,40(1):46-54.
7Abiru S, Migita K, Maeda Y, et al. Serum cytokines and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis[J]. Liver Intern, 2005, 26(1):39-45.
8Sebastiani G, Vario A, Ferrari A, et al. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C[J]. J Viral Hepat, 2006,13(3): 199-205.
9LokAS, Ghany MG, Everson GT, et al. Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon [J]. Hepatology, 2009,49 ( 4 ) : 1385 - 1387.
10BleibelW, Hussain G, LaiM, etal. High prevalence of hepatic steatosis and its impact on fibrosis in chronic hepatitis B[J]. Hepatology,2008,48(1):677- 678.
8Lok AS,McMahon BJ; Practice Guidelines Committee,American Association for the Study of Liver Diseases (AASLD).Chronic hepatitis B:update of recommendations.Hepatology,2004,39:857-861.
9Farrell GC,George J,Pauline de la M.Hall and McCullough A J,eds.Fatty liver disease:NASH and related disorders.Oxford:Blackwell Publishing,2005,1-22.
10American Gastroenterological Association.American Gastroenterological Association Medical Position Statement:nonalcoholic fatty liver disease.Gastroenterology,2002,123:1702-1704.
